Cardiac troponin T predicts mortality in patients end-stage renal disease

Circulation

Volumn 102, Issue 16, 2000, Pages 1964-1969

  Dierkes, Jutta ^a,b   Domröse, Ute ^a   Westphal, Sabine ^a   Ambrosch, Andreas ^a   Bosselmann, Hans Peter ^a   Neumann, Klaus Hinrich ^a   Luley, Claus ^a  

^a UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^b Institute of Clinical Chemistry   (Germany)

Author keywords

Cardiovascular diseases; Morbidity; Mortality

Indexed keywords

ALBUMIN; CREATININE; GLUCOSE; HOMOCYSTEINE; TRIACYLGLYCEROL; TROPONIN T;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0034680350     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.102.16.1964     Document Type: Article

References (30)

1. Morbidity and mortality of renal dialysis: An NIH consensus conference statement
2. Effect of age and diagnosis on survival of older patients beginning chronic dialysis
3. The European (European Dialysis and Transplantation Association-European Renal Association) registry
4. Mortality on dialysis: On the influence of early start, patient characteristics, and transplantation and acceptance rates
5. Mortality in patients receiving renal replacement therapy, a single center study
6. Renal replacement therapy in the United States: Data from the United States renal data system
7. Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients: A prospective study
8. Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease
9. Troponin T, a predictor of death in chronic haemodialysis patients
10. Prognostic value of cardiac troponin T and I elevations in renal disease patients without acute coronary syndromes: A 9-month outcome analysis
11. NKF-DOQI clinical practice guidelines for hemodialysis adequacy: National kidney foundation
12. High performance liquid chromatography method for rapid and accurate determination of homocysteine in plasma and serum
13. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intakes
14. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men
15. Plasma homocysteine levels and mortality in patients with coronary heart disease
16. Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: A population-based study
17. Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: A prospective study
18. Nutritional status and survival in end-stage renal disease patients
19. Enzymatic methyl esterification of erythrocyte membrane proteins is impaired in chronic renal failure: Evidence for high levels of the natural inhibitor S-adenosylhomocysteine
20. Plasma homocysteine concentration predicts mortality in non-insulin-dependent diabetic patients with and without albuminuria
21. Cardiac troponin T levels for risk stratification in acute myocardial infarction
22. Prospective study of the role of cardiac troponin T in patients admitted with unstable angina
23. Cardiac troponin-I accurately predicts myocardial injury in renal failure
24. Cardiac troponin I, cardiac troponin T, and creatine kinase MB in dialysis patients without ischemic heart disease: Evidence of cardiac troponin T expression in skeletal muscle
25. Cardiac troponin T in patients with end-stage renal disease: Absence of expression in truncal skeletal muscle
26. Cardiac troponin T isoforms expressed in renal diseased skeletal muscle will not cause false-positive results by the second generation cardiac troponin T assay by Boehringer Mannheim
27. Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients
28. High dose-B-vitamin treatment of hyperhomocysteinemia in dialysis patients
29. Response of hyperhomocysteinemia to folic acid supplementation in patients with end-stage renal disease
30. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels: c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators